Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Tidbits from the Disclosure Statement

Such Quarterly Payment shall be comprised of

100% of TPL’s share of the distribution of MMP Portfolio proceeds from PDS and 80% of

proceeds from the Core Flash and Fast Logic Portfolios, less operational and administrative

costs. TPL will continue to commercialize its CORE Flash and Fast Logic portfolios, but licenses

will, after Confirmation, be written by the IP Owners of the portfolios to whom the licenses will

be reconveyed as of the Effective Date.

What does TPL owe PTSC? Didn't we find TPL in breach of our agreement and we are owed money since we had to take over their montly costs?

Share
New Message
Please login to post a reply